Articles

CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide.

National University of Ireland Galway, Galway
Cancer Center Amsterdam, VU University Medical Center, Amsterdam
National University of Ireland Galway, Galway
National University of Ireland Galway, Galway
MaxCyte, Inc., Maryland
MaxCyte, Inc., Maryland
Cancer Center Amsterdam, VU University Medical Center, Amsterdam
Cancer Center Amsterdam, VU University Medical Center, Amsterdam
Cancer Center Amsterdam, VU University Medical Center, Amsterdam
National University of Ireland Galway, Galway
National University of Ireland Galway, Galway
National University of Ireland Galway, Galway
Haematologica Early view Dec 30, 2020 https://doi.org/10.3324/haematol.2020.271908